FierceBiotech [1] |
Drayson remote monitoring app misses endpoint in gestational diabetes [2] [1] trial
FierceBiotech Drayson Health's digital remote management app has failed to improve mean blood glucose level in women with gestational diabetes. The primary endpoint miss was the headline detail in a mixed set of data on the GDm-Health app. Investigators enrolled 203 … [3] |